PCYOX1
Prenylcysteine oxidase 1
Also known as: KIAA0908, PCL1, PCYOX_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHG3
- Gene
- PCYOX1
- Ensembl
- ENSG00000116005
- Chromosome
- 2
- Canonical length
- 505 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Prenylcysteine is released during the degradation of prenylated proteins. PCYOX1 catalyzes the degradation of prenylcysteine to yield free cysteines and a hydrophobic isoprenoid product (Tschantz et al., 1999 [PubMed 10585463]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
505 residues, UniProt reviewed canonical sequence.
>Q9UHG3|PCYOX1
1 MGRVVAELVS SLLGLWLLLC SCGCPEGAEL RAPPDKIAII GAGIGGTSAA YYLRQKFGKD
61 VKIDLFEREE VGGRLATMMV QGQEYEAGGS VIHPLNLHMK RFVKDLGLSA VQASGGLLGI
121 YNGETLVFEE SNWFIINVIK LVWRYGFQSL RMHMWVEDVL DKFMRIYRYQ SHDYAFSSVE
181 KLLHALGGDD FLGMLNRTLL ETLQKAGFSE KFLNEMIAPV MRVNYGQSTD INAFVGAVSL
241 SCSDSGLWAV EGGNKLVCSG LLQASKSNLI SGSVMYIEEK TKTKYTGNPT KMYEVVYQIG
301 TETRSDFYDI VLVATPLNRK MSNITFLNFD PPIEEFHQYY QHIVTTLVKG ELNTSIFSSR
361 PIDKFGLNTV LTTDNSDLFI NSIGIVPSVR EKEDPEPSTD GTYVWKIFSQ ETLTKAQILK
421 LFLSYDYAVK KPWLAYPHYK PPEKCPSIIL HDRLYYLNGI ECAASAMEMS AIAAHNAALL
481 AYHRWNGHTD MIDQDGLYEK LKTELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCYOX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- liver: 97 nTPM
- kidney: 86 nTPM
- skeletal muscle: 86 nTPM
- adipose tissue: 74 nTPM
- salivary gland: 66 nTPM
- parathyroid gland: 62 nTPM
Single-cell type
- alveolar cells type 1: 231 nCPM
- hepatocytes: 220 nCPM
- salivary acinar cells: 181 nCPM
- retinal pigment epithelial cells: 175 nCPM
- esophageal apical cells: 161 nCPM
- prostatic glandular cells: 160 nCPM
Immune cell
- basophil: 16 nTPM
- naive CD4 T-cell: 11 nTPM
- MAIT T-cell: 10 nTPM
- naive CD8 T-cell: 9.2 nTPM
- gdT-cell: 8.2 nTPM
- memory CD4 T-cell: 8 nTPM
Brain region
- choroid plexus: 82 nTPM
- hypothalamus: 79 nTPM
- pons: 73 nTPM
- midbrain: 67 nTPM
- medulla oblongata: 55 nTPM
- cerebral cortex: 55 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.49
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.07
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- FAD binding
- prenylcysteine oxidase activity
- farnesylcysteine lyase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PCYOX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCYOX1 as an antibody target. Whether an autoantibody or antibody against PCYOX1 could matter depends on whether native PCYOX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCYOX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCYOX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...